Validation of self-report of chest x-ray exam at a prostate, lung, colorectal and ovarian cancer screening trial center

Reviews on Recent Clinical Trials

Volumn 10, Issue 3, 2015, Pages 194-199

  Gren, Lisa H ^a   Lamerato, Lois E ^b   Wright, Patrick ^c   Marcus, Pamela M ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Lung; Screening; Self report; Validation; X ray

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; DATA BASE; FEMALE; GOLD STANDARD; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; SELF REPORT; SENSITIVITY ANALYSIS; THORAX RADIOGRAPHY; VALIDATION STUDY; AGED; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY (TOPIC); NATIONAL HEALTH ORGANIZATION; NEOPLASMS; ORGANIZATION AND MANAGEMENT; OVARIAN NEOPLASMS; PROCEDURES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOGRAPHY, THORACIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF REPORT; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 84946055301     PISSN: 15748871     EISSN: 18761038     Source Type: Journal    
DOI: 10.2174/1574887110666150731145929     Document Type: Article

References (18)

1. Gohagan JK, Prorok PC, Greenwald P, Kramer BS. The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. Rev Recent Clin Trials, 2015; 10(4):
2. Shokar NK, Vernon SW, Carlson CA. Validity of self-reported colorectal cancer test use in different racial/ethnic groups. Fam Pract 2011; 28(6): 683-8.
3. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of selfreported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17(4): 748-57.
4. McPhee SJ, Nguyen TT, Shema SJ, et al. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med 2002; 35(5): 463-73.
5. Partin MR, Grill J, Noorbaloochi S, et al. Validation of selfreported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomarkers Prev 2008; 17(4): 768-76.
6. White A, Vernon SW, Eberth JM, et al. Correlated of self-reported colorectal cancer screening accuracy in a multi-specialty medical group practice. Open J Epidemiol 2013; 3(1): 20-4.
7. Mandelson MT, LaCroix AZ, Anderson LA, Nadel MR, Lee NC. Comparison of self-reported fecal occult blood testing with automated laboratory records among older women in a health maintenance organization. Am J Epidemiol 1999; 150(6): 617-21.
8. Baier M, Calonge N, Cutter G, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomarkers Prev 2000; 9(2): 229-32.
9. Ferrante JM, Ohman-Strickland P, Hahn KA, et al. Self-report versus medical records for assessing cancer-preventive services delivery. Cancer Epidemiol Biomarkers Prev 2008; 17(11): 2987-94.
10. Fiscella K, Holt K, Meldrum S, Franks P. Disparities in preventive procedures: comparisons of self-report and Medicare claims data. BMC Health Serv Res 2006; 6: 122.
11. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 1993; 85(7): 566-70.
12. Lykins EL, Pavlik EL, Andrykowski MA. Validity of self-reports for routine repeat screening in an ovarian cancer screening program. Cancer Epidemiol Biomarkers Prev 2007; 16(3): 490-3.
13. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomarkers Prev 2003; 12(11): 1182-7.
14. U.S. Preventive Services Task Force. Lung cancer screening: Recommendation statement. Ann Intern Med. 2004; 140; 738-9.
15. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: A systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 2013; 159: 411-20.
16. Feinstein AR, Chiccheti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol 1990; 43 (6): 543-49.
17. Schenck AP, Klabunde CN, Warren JL, et al. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiol Biomarkers Prev 2008; 17(4): 799-804.
18. Parfrey PS. Randomized controlled trials 6: On contamination and estimating the actual treatment effect. Methods Mol Biol 2015; 1281: 249-59.